• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CHARLES & COLVARD ANNOUNCES NEW BRAND AMBASSADOR ACTRESS SKYLER SAMUELS

    4/9/24 8:00:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary
    Get the next $CTHR alert in real time by email

    RESEARCH TRIANGLE PARK, N.C., April 9, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab-created Made, Not Mined™ gems, is proud to announce its strategic partnership with American actress, Skyler Samuels, the Company's new brand ambassador.

    Charles & Colvard announces its strategic partnership with actress Skyler Samuels as its new brand ambassador.

    Samuels is best known for her roles in television series such as Wizards of Waverly Place, The Nine Lives of Chloe King, Marvel's The Gifted, Scream Queens, and American Horror Story. Samuels was handpicked to headline Hallmark Channel's prequel movie series, Aurora Teagarden Mysteries: Something New, in 2023. Skyler will debut two new Aurora mystery movies later this year.

    "Everyone deserves a little sparkle in their life, and I love that Charles & Colvard delivers that in a sustainable way. I am thrilled to find a brand that shares my affection for lab-grown diamonds and moissanite," said Skyler Samuels.

    As Charles & Colvard's new brand ambassador, Samuels will be the new face of the Company's mission to create conflict-free, beautiful, and ethical fine jewelry. Campaigns will be launched across various organic and paid channels, beginning with the Company's upcoming Mother's Day promotion.

    "Skyler Samuels shares our passion for lab-grown gems and our appreciation for responsibly made fine jewelry, which makes her a natural fit to represent our brand," said Don O'Connell, President and CEO of Charles & Colvard. "We are excited to partner with Skyler to bring more awareness to the Charles & Colvard brand, but also to educate consumers on the benefits of choosing lab-grown gems, such as our Forever One™ moissanite and Caydia® lab-grown diamonds," continued O'Connell.

    To preview Skyler's debut campaign, visit Skyler Samuels for Charles & Colvard.

    About Charles & Colvard, Ltd. 

    Charles & Colvard, Ltd. (NASDAQ:CTHR) believes that fine jewelry should be as ethical as it is exquisite. Charles & Colvard is the original creator of lab grown moissanite (a rare gemstone formed from silicon carbide). The Company brings revolutionary gems and fine jewelry to market by using exclusively Made, not Mined™ above ground gemstones and a dedication to 100% recycled precious metals. The Company's Forever One™ moissanite and Caydia® lab grown diamond brands provide exceptional quality, incredible value and a conscious approach to bridal, high fashion, and everyday jewelry. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park region. For more information, please visit www.charlesandcolvard.com.

    "I am thrilled to find a brand that shares my affection for lab-grown diamonds and moissanite," said Skyler Samuels.

    (PRNewsfoto/Charles & Colvard, Ltd.)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/charles--colvard-announces-new-brand-ambassador-actress-skyler-samuels-302110887.html

    SOURCE Charles & Colvard, Ltd.

    Get the next $CTHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTHR

    DatePrice TargetRatingAnalyst
    9/3/2021$3.50 → $3.75Buy
    Roth Capital
    More analyst ratings

    $CTHR
    SEC Filings

    View All

    SEC Form NT 10-Q filed by Charles & Colvard Ltd

    NT 10-Q - CHARLES & COLVARD LTD (0001015155) (Filer)

    2/17/26 4:30:19 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard Ltd filed SEC Form 8-K: Leadership Update

    8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    1/7/26 4:45:55 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard Ltd filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    10/16/25 4:30:36 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 9:15:15 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Charles & Colvard Partners with VideoShops to Bring Its Lab-Grown Jewelry and Customers to the Social Commerce Network with 50,000+ Influential Sellers

    RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. (OTC:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab-grown diamonds, today announced a strategic partnership with VideoShops, a next-generation social commerce network built to change how commerce flows through social with over 50,000 sellers transforming how people shop, share, and engage with today's consumers. "We believe this partnership underscores Charles & Colvard's ongoing commitment to digital innovation, transparency, and shoppa

    11/17/25 8:30:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD PARTNERS WITH ETHARA CAPITAL TO EXPAND LAB-GROWN DIAMOND OFFERINGS

    RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. (OTC:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab-grown diamonds, today announced plans to expand its lab-grown diamond ("LGD") offerings to consumers as well as wholesale markets with the supply chain support from its strategic investor, Ethara Capital ("Ethara"), whose affiliates pioneered Chemical Vapor Deposition LGD manufacturing, and own and operate over 3,000 diamond-growing machines today. In June, Ethara Capital announced a Con

    10/9/25 8:30:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard, Ltd. Announces Delisting from Nasdaq

    RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car

    4/22/25 4:45:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Ethara Capital Llc claimed ownership of 1,353,180 shares (SEC Form 3)

    3 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    10/9/25 3:30:05 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital reiterated coverage on Charles & Colvard with a new price target

    Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously

    9/3/21 8:46:46 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Leadership Updates

    Live Leadership Updates

    View All

    Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

    ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti

    11/14/24 4:00:00 PM ET
    $CTHR
    $MLSS
    Consumer Specialties
    Consumer Discretionary
    Industrial Specialties
    Health Care

    Charles & Colvard Joins Russell Microcap® Index

    RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines

    6/28/21 9:16:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Financials

    Live finance-specific insights

    View All

    CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024").  Management Commentary  "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica

    5/2/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET

    RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T

    4/23/24 4:08:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024").  Management Commentary  "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t

    2/13/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/26/24 7:00:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13G/A filed by Charles & Colvard Ltd (Amendment)

    SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/14/24 9:00:30 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    11/20/23 4:15:12 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary